Cingulate Inc (CING)
4.575
-0.08
(-1.61%)
USD |
NASDAQ |
Nov 22, 13:36
Cingulate Total Assets (Quarterly): 13.58M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.58M |
| June 30, 2024 | 5.127M |
| March 31, 2024 | 5.494M |
| December 31, 2023 | 3.491M |
| September 30, 2023 | 5.870M |
| June 30, 2023 | 5.227M |
| March 31, 2023 | 7.163M |
| December 31, 2022 | 11.41M |
| Date | Value |
|---|---|
| September 30, 2022 | 15.38M |
| June 30, 2022 | 13.80M |
| March 31, 2022 | 18.43M |
| December 31, 2021 | 22.89M |
| September 30, 2021 | 9.082M |
| June 30, 2021 | 6.693M |
| December 31, 2020 | 5.788M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.491M
Minimum
Dec 2023
22.89M
Maximum
Dec 2021
9.961M
Average
7.163M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| United Therapeutics Corp | 7.123B |
| Tonix Pharmaceuticals Holding Corp | 94.99M |
| Geovax Labs Inc | 11.11M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.542M |
| Shareholders Equity (Quarterly) | 12.04M |